N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and Prostate Cancer cohort Consortium

American Journal of Epidemiology

Volumn 174, Issue 11, 2011, Pages 1316-1322

  Cox, David G ^a,b   Dostal, Lucie ^c   Hunter, David J ^d   Le Marchand, Loïc ^f   Hoover, Robert ^e   Ziegler, Regina G ^e   Thun, Michael J ^g  

^a INSERM   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^g AMERICAN CANCER SOCIETY   (United States)

Author keywords

Arylamine N acetyltransferase; Breast neoplasms; NAT2 protein, human; Polymorphism, single nucleotide; Smoking

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; NAT2 PROTEIN, HUMAN;

ALCOHOL; COHORT ANALYSIS; ENZYME ACTIVITY; GENOTYPE-ENVIRONMENT INTERACTION; HEALTH IMPACT; HEALTH RISK; PHENOTYPE; POLYMORPHISM; PROTEIN; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; SPATIOTEMPORAL ANALYSIS; TOBACCO; WOMENS HEALTH;

ACETYLATION; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; PHENOTYPE; PROSPECTIVE STUDY; SMOKING; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; GENETICS; MALE; MENOPAUSE; META ANALYSIS; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

NICOTIANA TABACUM;

ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84856045453     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr257     Document Type: Article

References (17)

1. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoking. (IARC monographs on the evaluation of carcinogenic risks to humans, vol 83). Lyon, France: International Agency for Research on Cancer; 2002).
2. Secretan B, Straif K, Baan R, et al. A review of human carcinogens-part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033-1034.
3. Office of Environmental Health Hazard Assessment and California Air Resources Board, California Environmental Protection Agency. Proposed Identification of Environmental Tobacco Smoke as Toxic Air Contaminant. Sacramento, CA: California Environmental Protection Agency; 2005.
4. Collishaw NE, Boyd NF, Cantor KP, et al. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Toronto, Ontario, Canada: Ontario Tobacco Research Unit; 2009.
5. Ambrosone CB, Kropp S, Yang J, et al. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(1):15-26. (Pubitemid 351196269)
6. Hunter DJ, Riboli E, Haiman CA, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005;5(12):977-985.
7. Broderick P, Wang Y, Vijayakrishnan J, et al. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009;69(16):6633-6641.
8. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008;40(5):616-622. (Pubitemid 351601203)
9. Kuznetsov IB, McDuffie M, Moslehi R. A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype. Bioinformatics. 2009;25(9):1185-1186.
10. Gauderman WJ. Sample size requirements for matched casecontrol studies of gene-environment interaction. Stat Med. 2002;21(1):35-50. (Pubitemid 34065703)
11. Gauderman WJ, Morrison JM. QUANTO 1.1: A Computer Program for Power and Sample Size Calculations for Genetic-Epidemiology Studies. Los Angeles, CA: University of Southern California; 2006. (http://hydra.usc.edu/gxe).
12. Hamajima N, Hirose K, Tajima K, et al. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer. 2002;87(11):1234-1245.
13. Gu J, Liang D, Wang Y, et al. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res. 2005;581(1-2):97-104. (Pubitemid 40255898)
14. Hirao Y, Kim WJ, Fujimoto K. Environmental factors promoting bladder cancer. Curr Opin Urol. 2009;19(5):494-499.
15. Hung RJ, Boffetta P, Brennan P, et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer. 2004;110(4):598-604. (Pubitemid 38658026)
16. Lubin JH, Kogevinas M, Silverman D, et al. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Int J Epidemiol. 2007;36(1):236-241. (Pubitemid 47061604)
17. Ma QW, Lin GF, Chen JG, et al. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in Shanghai population: occupational and non-occupational bladder cancer patient groups. Biomed Environ Sci. 2004;17(3):291-298.